Publication | Open Access
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial
72
Citations
18
References
2024
Year
Sagimet Biosciences.
| Year | Citations | |
|---|---|---|
Page 1
Page 1